| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | JAK2 ART1 TRPM7 NANS PIK3CG PI4KA STK38 ROCK1 PRKDC PI4KAP2 STK38L | 1.61e-05 | 938 | 50 | 11 | GO:0016772 |
| GeneOntologyMolecularFunction | serotonin:sodium:chloride symporter activity | 1.84e-05 | 3 | 50 | 2 | GO:0005335 | |
| GeneOntologyMolecularFunction | monoamine:proton antiporter activity | 3.68e-05 | 4 | 50 | 2 | GO:0015311 | |
| GeneOntologyMolecularFunction | retinoic acid binding | 4.63e-05 | 28 | 50 | 3 | GO:0001972 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 9.14e-05 | 35 | 50 | 3 | GO:0015020 | |
| GeneOntologyMolecularFunction | kinase activity | 1.03e-04 | 764 | 50 | 9 | GO:0016301 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 1.08e-04 | 37 | 50 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | retinoid binding | 2.36e-04 | 48 | 50 | 3 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 2.51e-04 | 49 | 50 | 3 | GO:0019840 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 2.80e-04 | 363 | 50 | 6 | GO:0106310 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | 3.48e-04 | 709 | 50 | 8 | GO:0016773 | |
| GeneOntologyMolecularFunction | monoamine transmembrane transporter activity | 3.99e-04 | 12 | 50 | 2 | GO:0008504 | |
| GeneOntologyMolecularFunction | protein kinase activity | 6.95e-04 | 600 | 50 | 7 | GO:0004672 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 7.19e-04 | 70 | 50 | 3 | GO:1901618 | |
| GeneOntologyMolecularFunction | sodium:chloride symporter activity | 8.16e-04 | 17 | 50 | 2 | GO:0015378 | |
| GeneOntologyMolecularFunction | membrane insertase activity | 8.16e-04 | 17 | 50 | 2 | GO:0032977 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 8.30e-04 | 446 | 50 | 6 | GO:0004674 | |
| GeneOntologyMolecularFunction | monoatomic anion:sodium symporter activity | 1.02e-03 | 19 | 50 | 2 | GO:0015373 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 1.10e-03 | 81 | 50 | 3 | GO:0015370 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 1.50e-03 | 23 | 50 | 2 | GO:0015377 | |
| GeneOntologyMolecularFunction | cadherin binding | 1.55e-03 | 339 | 50 | 5 | GO:0045296 | |
| GeneOntologyMolecularFunction | phosphatidylinositol kinase activity | 1.92e-03 | 26 | 50 | 2 | GO:0052742 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 1.92e-03 | 26 | 50 | 2 | GO:0015296 | |
| GeneOntologyMolecularFunction | histone kinase activity | 2.23e-03 | 28 | 50 | 2 | GO:0035173 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 2.44e-03 | 107 | 50 | 3 | GO:0033293 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 2.99e-03 | 239 | 50 | 4 | GO:0031406 | |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 3.28e-03 | 34 | 50 | 2 | GO:0042910 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 3.30e-03 | 119 | 50 | 3 | GO:0015294 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 3.68e-03 | 599 | 50 | 6 | GO:0050839 | |
| GeneOntologyMolecularFunction | organic acid binding | 3.72e-03 | 254 | 50 | 4 | GO:0043177 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 3.96e-03 | 127 | 50 | 3 | GO:0008094 | |
| GeneOntologyMolecularFunction | protein carrier chaperone | 4.08e-03 | 38 | 50 | 2 | GO:0140597 | |
| GeneOntologyMolecularFunction | lipid kinase activity | 4.73e-03 | 41 | 50 | 2 | GO:0001727 | |
| GeneOntologyMolecularFunction | carbohydrate transmembrane transporter activity | 4.96e-03 | 42 | 50 | 2 | GO:0015144 | |
| GeneOntologyMolecularFunction | antiporter activity | 4.99e-03 | 138 | 50 | 3 | GO:0015297 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 5.80e-03 | 288 | 50 | 4 | GO:0016757 | |
| GeneOntologyMolecularFunction | symporter activity | 6.29e-03 | 150 | 50 | 3 | GO:0015293 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 6.38e-03 | 296 | 50 | 4 | GO:0015291 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 6.64e-03 | 153 | 50 | 3 | GO:0008194 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 9.01e-03 | 171 | 50 | 3 | GO:0015103 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 9.01e-03 | 171 | 50 | 3 | GO:0015081 | |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 9.60e-03 | 59 | 50 | 2 | GO:1901505 | |
| GeneOntologyMolecularFunction | clathrin binding | 1.09e-02 | 63 | 50 | 2 | GO:0030276 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 1.13e-02 | 758 | 50 | 6 | GO:0015318 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 1.73e-05 | 21 | 50 | 3 | GO:0052695 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 3.35e-05 | 26 | 50 | 3 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 3.35e-05 | 26 | 50 | 3 | GO:0006063 | |
| GeneOntologyBiologicalProcess | aminergic neurotransmitter loading into synaptic vesicle | 3.44e-05 | 4 | 50 | 2 | GO:0015842 | |
| GeneOntologyBiologicalProcess | positive regulation of apoptotic signaling pathway | 6.29e-05 | 174 | 50 | 5 | GO:2001235 | |
| GeneOntologyBiologicalProcess | post-embryonic hemopoiesis | 1.20e-04 | 7 | 50 | 2 | GO:0035166 | |
| GeneOntologyCellularComponent | clathrin-sculpted monoamine transport vesicle | 5.58e-05 | 5 | 50 | 2 | GO:0070081 | |
| GeneOntologyCellularComponent | clathrin-sculpted monoamine transport vesicle membrane | 5.58e-05 | 5 | 50 | 2 | GO:0070083 | |
| GeneOntologyCellularComponent | EMC complex | 2.49e-04 | 10 | 50 | 2 | GO:0072546 | |
| GeneOntologyCellularComponent | clathrin-sculpted vesicle | 6.59e-04 | 16 | 50 | 2 | GO:0060198 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | UGT1A4 UGT1A3 EMC3 ART1 EMC4 SLC18A1 AQP11 UGT1A5 SLC37A4 OR2W6P | 8.38e-04 | 1293 | 50 | 10 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | UGT1A4 UGT1A3 EMC3 ART1 EMC4 SLC18A1 AQP11 UGT1A5 SLC37A4 OR2W6P | 8.69e-04 | 1299 | 50 | 10 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | UGT1A4 UGT1A3 EMC3 ART1 EMC4 SLC18A1 AQP11 UGT1A5 SLC37A4 OR2W6P | 1.02e-03 | 1327 | 50 | 10 | GO:0042175 |
| MousePheno | abnormal mineral level | JAK2 NAA35 SLC38A10 NDRG1 FAM168A ART1 TRPM7 PIK3CG NR0B1 STEAP3 FNIP1 PRKDC SLC5A2 | 8.66e-06 | 1066 | 42 | 13 | MP:0000192 |
| MousePheno | abnormal mineral homeostasis | JAK2 NAA35 SLC38A10 NDRG1 FAM168A ART1 TRPM7 PIK3CG NR0B1 STEAP3 FNIP1 PRKDC SLC5A2 | 9.59e-06 | 1076 | 42 | 13 | MP:0005636 |
| MousePheno | abnormal circulating mineral level | JAK2 NAA35 SLC38A10 NDRG1 FAM168A ART1 TRPM7 NR0B1 STEAP3 FNIP1 PRKDC SLC5A2 | 2.08e-05 | 982 | 42 | 12 | MP:0006357 |
| MousePheno | abnormal bone marrow cell morphology/development | 3.42e-05 | 706 | 42 | 10 | MP:0002398 | |
| MousePheno | abnormal ion homeostasis | JAK2 NAA35 SLC38A10 NDRG1 FAM168A ART1 TRPM7 PIK3CG NR0B1 STEAP3 FNIP1 PRKDC SLC5A2 | 4.08e-05 | 1232 | 42 | 13 | MP:0001765 |
| MousePheno | abnormal bone marrow cell number | 9.31e-05 | 154 | 42 | 5 | MP:0000172 | |
| MousePheno | polychromatophilia | 1.07e-04 | 31 | 42 | 3 | MP:0005097 | |
| MousePheno | abnormal urine magnesium level | 1.18e-04 | 32 | 42 | 3 | MP:0011434 | |
| MousePheno | increased organ/body region tumor incidence | 1.57e-04 | 395 | 42 | 7 | MP:0010274 | |
| MousePheno | abnormal organ/body region tumor incidence | 1.72e-04 | 401 | 42 | 7 | MP:0013152 | |
| MousePheno | increased hemolymphoid system tumor incidence | 2.55e-04 | 191 | 42 | 5 | MP:0010296 | |
| MousePheno | abnormal myeloid leukocyte morphology | JAK2 SMAP1 ART1 EMC4 PIK3CG PI4KA APOF FNIP1 CHD9 PRKDC SLC37A4 SBNO2 | 2.96e-04 | 1292 | 42 | 12 | MP:0008250 |
| MousePheno | increased erythroid progenitor cell number | 3.28e-04 | 45 | 42 | 3 | MP:0003135 | |
| MousePheno | increased granulocyte number | 3.44e-04 | 597 | 42 | 8 | MP:0000322 | |
| MousePheno | abnormal platelet morphology | 3.56e-04 | 600 | 42 | 8 | MP:0004720 | |
| MousePheno | increased tumor necrosis factor secretion | 4.35e-04 | 119 | 42 | 4 | MP:0008560 | |
| MousePheno | abnormal iron level | 4.68e-04 | 218 | 42 | 5 | MP:0001770 | |
| MousePheno | increased circulating mineral level | 4.73e-04 | 626 | 42 | 8 | MP:0014547 | |
| MousePheno | decreased apoptosis | 4.78e-04 | 219 | 42 | 5 | MP:0006043 | |
| MousePheno | increased erythrocyte cell number | 4.93e-04 | 123 | 42 | 4 | MP:0003131 | |
| MousePheno | abnormal iron homeostasis | 5.20e-04 | 223 | 42 | 5 | MP:0005637 | |
| MousePheno | decreased cell death | 5.20e-04 | 223 | 42 | 5 | MP:0012555 | |
| MousePheno | increased myeloid cell number | 5.20e-04 | 343 | 42 | 6 | MP:0013663 | |
| MousePheno | abnormal granulocyte number | 5.32e-04 | 805 | 42 | 9 | MP:0020201 | |
| MousePheno | absent eyelids | 5.71e-04 | 12 | 42 | 2 | MP:0001341 | |
| MousePheno | abnormal tumor necrosis factor secretion | 5.98e-04 | 230 | 42 | 5 | MP:0008556 | |
| MousePheno | abnormal granulocyte morphology | 6.93e-04 | 835 | 42 | 9 | MP:0002441 | |
| MousePheno | abnormal innate immunity | 7.19e-04 | 667 | 42 | 8 | MP:0002419 | |
| MousePheno | increased mineral level | 7.26e-04 | 668 | 42 | 8 | MP:0014535 | |
| MousePheno | increased gland tumor incidence | 7.82e-04 | 139 | 42 | 4 | MP:0010288 | |
| MousePheno | absent B cells | 7.84e-04 | 14 | 42 | 2 | MP:0008071 | |
| MousePheno | decreased thymocyte apoptosis | 9.03e-04 | 15 | 42 | 2 | MP:0009542 | |
| MousePheno | abnormal immune organ physiology | 9.15e-04 | 145 | 42 | 4 | MP:0003762 | |
| MousePheno | increased tumor incidence | 9.21e-04 | 530 | 42 | 7 | MP:0002020 | |
| MousePheno | increased testis tumor incidence | 1.03e-03 | 16 | 42 | 2 | MP:0006262 | |
| MousePheno | abnormal circulating phosphate level | 1.04e-03 | 260 | 42 | 5 | MP:0001565 | |
| MousePheno | abnormal phosphate level | 1.07e-03 | 262 | 42 | 5 | MP:0020885 | |
| MousePheno | abnormal platelet cell number | 1.12e-03 | 397 | 42 | 6 | MP:0011898 | |
| Domain | Kinase-like_dom | 5.78e-06 | 542 | 46 | 9 | IPR011009 | |
| Domain | PI3/4_kinase_CS | 6.23e-06 | 15 | 46 | 3 | IPR018936 | |
| Domain | PI3Kc | 7.66e-06 | 16 | 46 | 3 | SM00146 | |
| Domain | - | 7.66e-06 | 16 | 46 | 3 | 1.10.1070.11 | |
| Domain | PI3_4_KINASE_1 | 1.11e-05 | 18 | 46 | 3 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 1.11e-05 | 18 | 46 | 3 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 1.11e-05 | 18 | 46 | 3 | IPR000403 | |
| Domain | PI3_PI4_kinase | 1.11e-05 | 18 | 46 | 3 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 1.11e-05 | 18 | 46 | 3 | PS50290 | |
| Domain | UDPGT | 1.80e-05 | 21 | 46 | 3 | PS00375 | |
| Domain | UDPGT | 1.80e-05 | 21 | 46 | 3 | PF00201 | |
| Domain | UDP_glucos_trans | 1.80e-05 | 21 | 46 | 3 | IPR002213 | |
| Domain | BRK | 8.85e-05 | 6 | 46 | 2 | SM00592 | |
| Domain | BRK_domain | 8.85e-05 | 6 | 46 | 2 | IPR006576 | |
| Domain | BRK | 8.85e-05 | 6 | 46 | 2 | PF07533 | |
| Domain | Pkinase_C | 1.02e-04 | 37 | 46 | 3 | IPR017892 | |
| Domain | Pkinase_C | 1.50e-04 | 42 | 46 | 3 | PF00433 | |
| Domain | PI3Ka | 2.11e-04 | 9 | 46 | 2 | PF00613 | |
| Domain | - | 2.11e-04 | 9 | 46 | 2 | 1.25.40.70 | |
| Domain | PI3Ka | 2.11e-04 | 9 | 46 | 2 | SM00145 | |
| Domain | PIK_HELICAL | 2.64e-04 | 10 | 46 | 2 | PS51545 | |
| Domain | PI_Kinase | 2.64e-04 | 10 | 46 | 2 | IPR015433 | |
| Domain | PInositide-3_kin_accessory_dom | 2.64e-04 | 10 | 46 | 2 | IPR001263 | |
| Domain | AGC-kinase_C | 3.54e-04 | 56 | 46 | 3 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 3.54e-04 | 56 | 46 | 3 | PS51285 | |
| Domain | S_TK_X | 3.54e-04 | 56 | 46 | 3 | SM00133 | |
| Domain | MFS | 9.00e-04 | 77 | 46 | 3 | IPR011701 | |
| Domain | MFS_1 | 9.00e-04 | 77 | 46 | 3 | PF07690 | |
| Domain | Chromo_domain | 1.58e-03 | 24 | 46 | 2 | IPR023780 | |
| Domain | Chromo | 1.86e-03 | 26 | 46 | 2 | PF00385 | |
| Domain | CHROMO_2 | 2.15e-03 | 28 | 46 | 2 | PS50013 | |
| Domain | CHROMO_1 | 2.15e-03 | 28 | 46 | 2 | PS00598 | |
| Domain | MFS | 2.38e-03 | 108 | 46 | 3 | PS50850 | |
| Domain | SNF2_N | 2.81e-03 | 32 | 46 | 2 | PF00176 | |
| Domain | SNF2_N | 2.81e-03 | 32 | 46 | 2 | IPR000330 | |
| Domain | Chromodomain-like | 2.81e-03 | 32 | 46 | 2 | IPR016197 | |
| Domain | CHROMO | 2.98e-03 | 33 | 46 | 2 | SM00298 | |
| Domain | Chromo/shadow_dom | 2.98e-03 | 33 | 46 | 2 | IPR000953 | |
| Domain | MFS_dom | 4.38e-03 | 134 | 46 | 3 | IPR020846 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 9.41e-06 | 15 | 40 | 3 | MM15697 | |
| Pathway | REACTOME_HEME_DEGRADATION | 2.33e-05 | 20 | 40 | 3 | MM14721 | |
| Pathway | REACTOME_PREDNISONE_ADME | 3.60e-05 | 23 | 40 | 3 | MM16639 | |
| Pathway | REACTOME_GLUCURONIDATION | 4.11e-05 | 24 | 40 | 3 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 4.66e-05 | 25 | 40 | 3 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 4.66e-05 | 25 | 40 | 3 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 4.66e-05 | 25 | 40 | 3 | M605 | |
| Pathway | WP_GLUCURONIDATION | 5.26e-05 | 26 | 40 | 3 | M39404 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 6.60e-05 | 28 | 40 | 3 | M19580 | |
| Pathway | REACTOME_METABOLISM_OF_PORPHYRINS | 9.92e-05 | 32 | 40 | 3 | MM14719 | |
| Pathway | WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION | 1.67e-04 | 38 | 40 | 3 | M39854 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 2.09e-04 | 41 | 40 | 3 | M7399 | |
| Pathway | REACTOME_ASPIRIN_ADME | 2.59e-04 | 44 | 40 | 3 | M45014 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_DEATH_GENES | 2.59e-04 | 44 | 40 | 3 | M27499 | |
| Pathway | REACTOME_ASPIRIN_ADME | 2.77e-04 | 45 | 40 | 3 | MM15694 | |
| Pathway | BIOCARTA_CELL2CELL_PATHWAY | 2.79e-04 | 9 | 40 | 2 | MM1366 | |
| Pathway | KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION | 3.16e-04 | 116 | 40 | 4 | M2164 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 4.01e-04 | 51 | 40 | 3 | M17726 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 4.25e-04 | 52 | 40 | 3 | M14171 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 5.01e-04 | 55 | 40 | 3 | M14933 | |
| Pathway | BIOCARTA_CELL2CELL_PATHWAY | 5.09e-04 | 12 | 40 | 2 | M12851 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K | 5.09e-04 | 12 | 40 | 2 | M27905 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K | 5.09e-04 | 12 | 40 | 2 | MM15623 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_SEVERAL_ADDITIONAL_CELL_DEATH_GENES_WHOSE_SPECIFIC_ROLES_IN_P53_DEPENDENT_APOPTOSIS_REMAIN_UNCERTAIN | 6.99e-04 | 14 | 40 | 2 | M27629 | |
| Pathway | KEGG_RETINOL_METABOLISM | 7.82e-04 | 64 | 40 | 3 | M9488 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 1.02e-03 | 70 | 40 | 3 | M16794 | |
| Pathway | WP_LEPTININSULIN_SIGNALING_OVERLAP | 1.04e-03 | 17 | 40 | 2 | M39517 | |
| Pathway | REACTOME_SIGNALING_BY_ERYTHROPOIETIN | 1.04e-03 | 17 | 40 | 2 | MM15584 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 1.10e-03 | 72 | 40 | 3 | M9257 | |
| Pathway | BIOCARTA_PAR1_PATHWAY | 1.30e-03 | 19 | 40 | 2 | MM1514 | |
| Pathway | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | 1.30e-03 | 19 | 40 | 2 | M27362 | |
| Pathway | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | 1.30e-03 | 19 | 40 | 2 | MM15107 | |
| Pathway | BIOCARTA_PAR1_PATHWAY | 1.30e-03 | 19 | 40 | 2 | M3494 | |
| Pathway | BIOCARTA_ECM_PATHWAY | 1.30e-03 | 19 | 40 | 2 | M6355 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_CYTOCHROME_C_RELEASE | 1.44e-03 | 20 | 40 | 2 | M27628 | |
| Pathway | WP_LEPTININSULIN_SIGNALING_OVERLAP | 1.44e-03 | 20 | 40 | 2 | MM15867 | |
| Pathway | BIOCARTA_ECM_PATHWAY | 1.59e-03 | 21 | 40 | 2 | MM1390 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 1.72e-03 | 84 | 40 | 3 | M1008 | |
| Pathway | WP_HIPPOYAP_SIGNALING | 1.75e-03 | 22 | 40 | 2 | M39821 | |
| Pathway | WP_ESTROGEN_METABOLISM | 1.75e-03 | 22 | 40 | 2 | MM15888 | |
| Pathway | REACTOME_RHOBTB1_GTPASE_CYCLE | 1.91e-03 | 23 | 40 | 2 | M41817 | |
| Pathway | BIOCARTA_GLEEVEC_PATHWAY | 1.91e-03 | 23 | 40 | 2 | MM1424 | |
| Pathway | BIOCARTA_GLEEVEC_PATHWAY | 1.91e-03 | 23 | 40 | 2 | M7897 | |
| Pathway | BIOCARTA_TPO_PATHWAY | 2.08e-03 | 24 | 40 | 2 | M11520 | |
| Pathway | BIOCARTA_TPO_PATHWAY | 2.26e-03 | 25 | 40 | 2 | MM1519 | |
| Pathway | REACTOME_SIGNALING_BY_ERYTHROPOIETIN | 2.26e-03 | 25 | 40 | 2 | M27865 | |
| Pathway | REACTOME_RHOBTB1_GTPASE_CYCLE | 2.26e-03 | 25 | 40 | 2 | MM15608 | |
| Pathway | WP_EPO_RECEPTOR_SIGNALING | 2.44e-03 | 26 | 40 | 2 | M39687 | |
| Pathway | WP_EPO_RECEPTOR_SIGNALING | 2.44e-03 | 26 | 40 | 2 | MM15896 | |
| Pathway | BIOCARTA_GH_PATHWAY | 2.63e-03 | 27 | 40 | 2 | M9043 | |
| Pubmed | HIV-1 incorporates and proteolytically processes human NDR1 and NDR2 serine-threonine kinases. | 2.97e-09 | 3 | 51 | 3 | 15582665 | |
| Pubmed | Ndr kinases regulate retinal interneuron proliferation and homeostasis. | 2.96e-08 | 5 | 51 | 3 | 30135513 | |
| Pubmed | Loss of NDR1/2 kinases impairs endomembrane trafficking and autophagy leading to neurodegeneration. | 5.92e-08 | 6 | 51 | 3 | 36446521 | |
| Pubmed | 2.48e-07 | 9 | 51 | 3 | 22511988 | ||
| Pubmed | 2.48e-07 | 9 | 51 | 3 | 1339448 | ||
| Pubmed | 3.54e-07 | 10 | 51 | 3 | 23642732 | ||
| Pubmed | 3.54e-07 | 10 | 51 | 3 | 11465080 | ||
| Pubmed | 3.54e-07 | 10 | 51 | 3 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 3.54e-07 | 10 | 51 | 3 | 22558097 | |
| Pubmed | 6.47e-07 | 12 | 51 | 3 | 19419973 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 6.47e-07 | 12 | 51 | 3 | 11434514 | |
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 8.41e-07 | 13 | 51 | 3 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 8.41e-07 | 13 | 51 | 3 | 25246029 | |
| Pubmed | 1.07e-06 | 14 | 51 | 3 | 21646302 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 1.07e-06 | 14 | 51 | 3 | 10836148 | |
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 1.07e-06 | 14 | 51 | 3 | 14672974 | |
| Pubmed | 1.07e-06 | 14 | 51 | 3 | 9295054 | ||
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 1.64e-06 | 16 | 51 | 3 | 19414484 | |
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 1.99e-06 | 17 | 51 | 3 | 20639394 | |
| Pubmed | Behavior of CD34+ cells isolated from patients with polycythemia vera in NOD/SCID mice. | 2.11e-06 | 2 | 51 | 2 | 17764815 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 8068691 | ||
| Pubmed | NDR functions as a physiological YAP1 kinase in the intestinal epithelium. | 2.11e-06 | 2 | 51 | 2 | 25601544 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 12871984 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 24641623 | ||
| Pubmed | Chromosomal localization of the human vesicular amine transporter genes. | 2.11e-06 | 2 | 51 | 2 | 7905859 | |
| Pubmed | Constitutively active NDR1-PIF kinase functions independent of MST1 and hMOB1 signalling. | 2.11e-06 | 2 | 51 | 2 | 24747552 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 11431013 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 26338179 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 35524772 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 8643547 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 14570768 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 15037617 | ||
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 2.83e-06 | 19 | 51 | 3 | 23281178 | |
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | 5.88e-06 | 24 | 51 | 3 | 24625756 | |
| Pubmed | Human NDR kinases control G(1)/S cell cycle transition by directly regulating p21 stability. | 6.32e-06 | 3 | 51 | 2 | 21262772 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 23897809 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 12493777 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 16189177 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 12051676 | ||
| Pubmed | Ablation of the kinase NDR1 predisposes mice to the development of T cell lymphoma. | 6.32e-06 | 3 | 51 | 2 | 20551432 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 29678906 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 34612768 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 12827358 | ||
| Pubmed | [Expression of GLUT-1, p63 and DNA-Pkcs in serous ovarian tumors and their significance]. | 6.32e-06 | 3 | 51 | 2 | 18246802 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 26443704 | ||
| Pubmed | Jak2-mediated phosphorylation of Atoh1 is critical for medulloblastoma growth. | 6.32e-06 | 3 | 51 | 2 | 29168692 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 23188716 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 31317476 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 23611809 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 21383159 | ||
| Pubmed | Ski regulates Hippo and TAZ signaling to suppress breast cancer progression. | 7.26e-06 | 84 | 51 | 4 | 25670202 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 1.10e-05 | 736 | 51 | 8 | 29676528 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 19062280 | ||
| Pubmed | Genetic variations and haplotypes of UDP-glucuronosyltransferase 1A locus in a Korean population. | 1.26e-05 | 4 | 51 | 2 | 18223459 | |
| Pubmed | P2X(3) receptor expression at early stage of mouse embryogenesis. | 1.26e-05 | 4 | 51 | 2 | 12351197 | |
| Pubmed | Mechanism of activation of NDR (nuclear Dbf2-related) protein kinase by the hMOB1 protein. | 1.26e-05 | 4 | 51 | 2 | 15197186 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 22053215 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 12644700 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 9535849 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 9271343 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 32248560 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 19726747 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 30018336 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 18678286 | ||
| Pubmed | 1.89e-05 | 378 | 51 | 6 | 34315543 | ||
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 18771702 | ||
| Pubmed | NDR1 protein kinase promotes IL-17- and TNF-α-mediated inflammation by competitively binding TRAF3. | 2.10e-05 | 5 | 51 | 2 | 28219902 | |
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 7677729 | ||
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 15664519 | ||
| Pubmed | Human Mob proteins regulate the NDR1 and NDR2 serine-threonine kinases. | 2.10e-05 | 5 | 51 | 2 | 15067004 | |
| Pubmed | Rassf5 and Ndr kinases regulate neuronal polarity through Par3 phosphorylation in a novel pathway. | 2.10e-05 | 5 | 51 | 2 | 24928906 | |
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 15057901 | ||
| Pubmed | TRPM7 ion channels are required for sustained phosphoinositide 3-kinase signaling in lymphocytes. | 2.10e-05 | 5 | 51 | 2 | 18590694 | |
| Pubmed | TGFβR-SMAD3 Signaling Induces Resistance to PARP Inhibitors in the Bone Marrow Microenvironment. | 2.10e-05 | 5 | 51 | 2 | 33027668 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | 2.13e-05 | 1061 | 51 | 9 | 33845483 | |
| Pubmed | 2.63e-05 | 401 | 51 | 6 | 25852190 | ||
| Pubmed | Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population. | 3.15e-05 | 6 | 51 | 2 | 19204906 | |
| Pubmed | LKB1/STK11 Is a Tumor Suppressor in the Progression of Myeloproliferative Neoplasms. | 3.15e-05 | 6 | 51 | 2 | 33579786 | |
| Pubmed | 3.15e-05 | 6 | 51 | 2 | 8661734 | ||
| Pubmed | 3.94e-05 | 129 | 51 | 4 | 23022380 | ||
| Pubmed | 4.25e-05 | 437 | 51 | 6 | 20562859 | ||
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 4.41e-05 | 7 | 51 | 2 | 8467709 | |
| Pubmed | EMC3 regulates mesenchymal cell survival via control of the mitotic spindle assembly. | 4.41e-05 | 7 | 51 | 2 | 36624844 | |
| Pubmed | 4.41e-05 | 7 | 51 | 2 | 8464825 | ||
| Pubmed | 4.93e-05 | 449 | 51 | 6 | 31732153 | ||
| Pubmed | 4.94e-05 | 272 | 51 | 5 | 31010829 | ||
| Pubmed | 5.87e-05 | 8 | 51 | 2 | 17179145 | ||
| Pubmed | 5.87e-05 | 8 | 51 | 2 | 20610558 | ||
| Pubmed | Involvement of human UGT2B7 and 2B15 in rofecoxib metabolism. | 5.87e-05 | 8 | 51 | 2 | 12695355 | |
| Pubmed | Nurr1 is required for maintenance of maturing and adult midbrain dopamine neurons. | 5.87e-05 | 8 | 51 | 2 | 20016108 | |
| Pubmed | 5.87e-05 | 8 | 51 | 2 | 22579593 | ||
| Pubmed | 5.87e-05 | 8 | 51 | 2 | 8632996 | ||
| Pubmed | 7.45e-05 | 1247 | 51 | 9 | 27684187 | ||
| Pubmed | 7.48e-05 | 708 | 51 | 7 | 39231216 | ||
| Pubmed | Human metabolic individuality in biomedical and pharmaceutical research. | 8.22e-05 | 57 | 51 | 3 | 21886157 | |
| Pubmed | 9.32e-05 | 504 | 51 | 6 | 34432599 | ||
| Pubmed | The ER membrane protein complex is a transmembrane domain insertase. | 9.42e-05 | 10 | 51 | 2 | 29242231 | |
| Pubmed | Structural basis for membrane insertion by the human ER membrane protein complex. | 9.42e-05 | 10 | 51 | 2 | 32439656 | |
| Pubmed | EMC Is Required to Initiate Accurate Membrane Protein Topogenesis. | 9.42e-05 | 10 | 51 | 2 | 30415835 | |
| Pubmed | CAPS1 regulates catecholamine loading of large dense-core vesicles. | 9.42e-05 | 10 | 51 | 2 | 15820695 | |
| Interaction | LYN interactions | 3.64e-05 | 720 | 47 | 9 | int:LYN | |
| Interaction | RHOD interactions | 4.75e-05 | 572 | 47 | 8 | int:RHOD | |
| Interaction | PI4KAP2 interactions | 5.30e-05 | 5 | 47 | 2 | int:PI4KAP2 | |
| Interaction | UGT1A3 interactions | 5.30e-05 | 5 | 47 | 2 | int:UGT1A3 | |
| Interaction | CDH1 interactions | 6.00e-05 | 768 | 47 | 9 | int:CDH1 | |
| Cytoband | 2q37 | 5.68e-06 | 31 | 51 | 3 | 2q37 | |
| Cytoband | 5q33.3 | 7.44e-04 | 36 | 51 | 2 | 5q33.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q11 | 1.22e-03 | 419 | 51 | 4 | chr22q11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q37 | 2.06e-03 | 226 | 51 | 3 | chr2q37 | |
| GeneFamily | UDP glucuronosyltransferases | 2.65e-05 | 32 | 33 | 3 | 363 | |
| GeneFamily | Solute carriers | 6.96e-04 | 395 | 33 | 5 | 752 | |
| GeneFamily | Cyclins|Mediator complex | 1.65e-03 | 33 | 33 | 2 | 1061 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | 1.01e-05 | 804 | 48 | 10 | gudmap_developingGonad_e12.5_ovary_1000 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.28e-06 | 200 | 51 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.09e-05 | 168 | 51 | 4 | 8072d0496b7b730c4601009eaa69ec5366d26d73 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_neutrophil-granulo-eo/baso/mast-basophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.90e-05 | 176 | 51 | 4 | 581d78811b2d99f38a2c7cc268aeb1cf932379c2 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-05 | 182 | 51 | 4 | bdeebbfffc1308a29b721a5f8fed23a28d7a2f2f | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-05 | 182 | 51 | 4 | be8dd52898525ce6632af0adc2801944f3ac10bd | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-05 | 182 | 51 | 4 | faf0dfa3adc2d2706b6942b5127093ccdc856447 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.82e-05 | 184 | 51 | 4 | c86ed59fed687cdaaf7e9c4418d2e3e2c4111cca | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.82e-05 | 184 | 51 | 4 | 7c256bcfa07c5ff55aad0833e8712b0456b5832b | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.95e-05 | 185 | 51 | 4 | 3e3217c99719fd1d2fa94e16be7712a7e5077152 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.95e-05 | 185 | 51 | 4 | 0ff4148b4701003d9d594e0da8261176fb13aa59 | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-05 | 188 | 51 | 4 | c1f64311ff05093b2f4f672e33f5f75e3bc8a8db | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-05 | 188 | 51 | 4 | b483b4629695764568bcbd1d527d614824147783 | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class | 7.89e-05 | 199 | 51 | 4 | 99a65887d3c8a2cde26693dd74404b101bba9d58 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 8.04e-05 | 200 | 51 | 4 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| Drug | phenanthridine | 1.77e-07 | 23 | 50 | 4 | CID000009189 | |
| Drug | H-Ni | 4.05e-07 | 28 | 50 | 4 | CID000445665 | |
| Drug | dihydroartemisinin | 5.41e-07 | 30 | 50 | 4 | CID000107770 | |
| Drug | 4-ethylphenol | 6.20e-07 | 31 | 50 | 4 | CID000031242 | |
| Drug | AC1MRQNQ | 8.29e-07 | 9 | 50 | 3 | CID003522271 | |
| Drug | DHPASiU | 8.29e-07 | 9 | 50 | 3 | CID000197602 | |
| Drug | Chebi:32663 | 8.29e-07 | 9 | 50 | 3 | CID005460873 | |
| Drug | 3-iodophenol | 8.29e-07 | 9 | 50 | 3 | CID000012272 | |
| Drug | AC1L4J7U | 8.29e-07 | 9 | 50 | 3 | CID000186631 | |
| Drug | 4-nitrophenyl)imidazole | 1.62e-06 | 11 | 50 | 3 | CID000123155 | |
| Drug | AC1O5XMV | 1.62e-06 | 11 | 50 | 3 | CID006442661 | |
| Drug | harmol | 1.77e-06 | 40 | 50 | 4 | CID000068094 | |
| Drug | N-OH-DABZ | 2.16e-06 | 12 | 50 | 3 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 2.16e-06 | 12 | 50 | 3 | CID000088735 | |
| Drug | 2,4,6-TCB | 2.16e-06 | 12 | 50 | 3 | CID000037247 | |
| Drug | 7,7,7-triphenylheptanoic acid | 2.16e-06 | 12 | 50 | 3 | CID000276709 | |
| Drug | nonanoyl-N-methylglucamide | 2.16e-06 | 12 | 50 | 3 | CID000160090 | |
| Drug | 7,8-benzoquinoline | 2.38e-06 | 43 | 50 | 4 | CID000009191 | |
| Drug | anthraflavic acid | 2.62e-06 | 44 | 50 | 4 | CID000006776 | |
| Drug | tritanol | 2.81e-06 | 13 | 50 | 3 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 2.81e-06 | 13 | 50 | 3 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 2.81e-06 | 13 | 50 | 3 | CID000000411 | |
| Drug | propranolol glucuronide | 3.57e-06 | 14 | 50 | 3 | CID000119515 | |
| Drug | PCB-61 | 3.57e-06 | 14 | 50 | 3 | CID000036401 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 4.45e-06 | 15 | 50 | 3 | CID000040469 | |
| Drug | coumarin-3-carboxylic acid | 4.45e-06 | 15 | 50 | 3 | CID000010752 | |
| Drug | sulforaphane nitrile | 4.45e-06 | 15 | 50 | 3 | CID000543743 | |
| Drug | afloqualone | 4.45e-06 | 15 | 50 | 3 | CID000002040 | |
| Drug | naphthyl sulphate | 4.45e-06 | 15 | 50 | 3 | CID000114775 | |
| Drug | 3-acrylamidophenylboronic acid | 4.73e-06 | 2 | 50 | 2 | CID010321331 | |
| Drug | reserpic acid | 4.73e-06 | 2 | 50 | 2 | CID000065747 | |
| Drug | azidoiodoketanserin | 4.73e-06 | 2 | 50 | 2 | CID003037022 | |
| Drug | afloqualone | 4.73e-06 | 2 | 50 | 2 | ctd:C033541 | |
| Drug | methyl reserpate | 4.73e-06 | 2 | 50 | 2 | CID000073532 | |
| Drug | AC1L9OXR | 4.73e-06 | 2 | 50 | 2 | CID000450456 | |
| Drug | quercetin-3,4'-diglucoside | 5.47e-06 | 16 | 50 | 3 | CID005320835 | |
| Drug | 1'-hydroxyestragole | 5.47e-06 | 16 | 50 | 3 | CID000040003 | |
| Drug | bilirubin-phosphate | 5.47e-06 | 16 | 50 | 3 | CID005497144 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 6.63e-06 | 17 | 50 | 3 | CID000003573 | |
| Drug | 6-hydroxychrysene | 6.63e-06 | 17 | 50 | 3 | CID000037766 | |
| Drug | GR 55562 | 7.94e-06 | 18 | 50 | 3 | CID000128017 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 7.94e-06 | 18 | 50 | 3 | CID000152226 | |
| Drug | Br 2 | 7.94e-06 | 18 | 50 | 3 | CID003060900 | |
| Drug | SureCN12722713 | 7.94e-06 | 18 | 50 | 3 | CID005488034 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 7.94e-06 | 18 | 50 | 3 | CID000036614 | |
| Drug | ApApG | 7.94e-06 | 18 | 50 | 3 | CID003081975 | |
| Drug | C1 11-32 | 7.94e-06 | 18 | 50 | 3 | CID000443077 | |
| Drug | C11131 | 7.94e-06 | 18 | 50 | 3 | CID000443076 | |
| Drug | almokalant | 9.42e-06 | 19 | 50 | 3 | CID003033962 | |
| Drug | 9-OH-risperidone | 9.42e-06 | 19 | 50 | 3 | CID000475100 | |
| Drug | 5alpha-spirostan-3beta-ol | 9.42e-06 | 19 | 50 | 3 | CID000091433 | |
| Drug | tectochrysin | 1.11e-05 | 20 | 50 | 3 | CID005281954 | |
| Drug | AC1L1OBF | 1.11e-05 | 20 | 50 | 3 | CID000032736 | |
| Drug | 4'-hydroxydiclofenac | 1.11e-05 | 20 | 50 | 3 | CID000116545 | |
| Drug | 2-hydroxyestradiol | 1.11e-05 | 63 | 50 | 4 | CID000009684 | |
| Drug | naringenin | 1.21e-05 | 136 | 50 | 5 | CID000000932 | |
| Drug | imipramine | 1.23e-05 | 235 | 50 | 6 | CID000003696 | |
| Drug | estriol-16-glucuronide | 1.29e-05 | 21 | 50 | 3 | CID000122281 | |
| Drug | dulcin | 1.29e-05 | 21 | 50 | 3 | CID000009013 | |
| Drug | Benzamidoxime hydrochloride | 1.29e-05 | 21 | 50 | 3 | CID000069186 | |
| Drug | amonafide | 1.49e-05 | 22 | 50 | 3 | CID000050515 | |
| Drug | N-methylpiperazine | 1.49e-05 | 22 | 50 | 3 | CID000053167 | |
| Drug | amidoxime | 1.71e-05 | 23 | 50 | 3 | CID000465967 | |
| Drug | estradiol-3-glucuronide | 1.71e-05 | 23 | 50 | 3 | CID000066651 | |
| Drug | AS-3201 | 1.95e-05 | 24 | 50 | 3 | CID000153948 | |
| Drug | eugenol | 2.00e-05 | 73 | 50 | 4 | CID000003314 | |
| Drug | 5-MOP | 2.22e-05 | 25 | 50 | 3 | CID000002355 | |
| Drug | TBZ1 | 2.22e-05 | 25 | 50 | 3 | CID000122665 | |
| Drug | AzMC | 2.22e-05 | 25 | 50 | 3 | CID000064986 | |
| Drug | N-acetylbenzidine | 2.22e-05 | 25 | 50 | 3 | CID000018787 | |
| Drug | 5,6-benzoquinoline | 2.22e-05 | 25 | 50 | 3 | CID000006796 | |
| Drug | N-phenylmaleimide | 2.22e-05 | 25 | 50 | 3 | CID000013662 | |
| Drug | 7-hydroxycoumarin | 2.23e-05 | 75 | 50 | 4 | CID005281426 | |
| Drug | N-benzylformamide | 2.35e-05 | 76 | 50 | 4 | CID000080654 | |
| Drug | DiMeIQx | 2.81e-05 | 27 | 50 | 3 | CID000104739 | |
| Drug | diflunisal | 2.81e-05 | 27 | 50 | 3 | CID000003059 | |
| Drug | 6-fluorometaraminol | 2.83e-05 | 4 | 50 | 2 | CID000159475 | |
| Drug | norsalsolinol | 2.83e-05 | 4 | 50 | 2 | CID000036937 | |
| Drug | N-hydroxy-4-aminobiphenyl | 3.14e-05 | 28 | 50 | 3 | CID000081261 | |
| Drug | CARMINE | 3.14e-05 | 28 | 50 | 3 | CID000014749 | |
| Drug | erucin | 3.14e-05 | 28 | 50 | 3 | CID000078160 | |
| Drug | AC1L1JAL | 3.50e-05 | 29 | 50 | 3 | CID000004954 | |
| Drug | 7-hydroxy-4-trifluoromethylcoumarin | 3.50e-05 | 29 | 50 | 3 | CID005375667 | |
| Drug | trans-3'-hydroxycotinine | 3.50e-05 | 29 | 50 | 3 | CID000000414 | |
| Drug | 7-hydroxycoumarin glucuronide | 3.50e-05 | 29 | 50 | 3 | CID000125641 | |
| Drug | iberin | 3.50e-05 | 29 | 50 | 3 | CID000010455 | |
| Drug | ciprofibrate | 3.53e-05 | 170 | 50 | 5 | CID000002763 | |
| Drug | 7-ethoxycoumarin | 3.83e-05 | 86 | 50 | 4 | CID000035703 | |
| Drug | tolcapone | 3.88e-05 | 30 | 50 | 3 | CID004659569 | |
| Drug | paricalcitol | 3.88e-05 | 30 | 50 | 3 | CID005281104 | |
| Drug | AC1L9E0Q | 3.88e-05 | 30 | 50 | 3 | CID000443095 | |
| Drug | menthol | 4.00e-05 | 87 | 50 | 4 | CID000001254 | |
| Drug | PCB 156 | 4.29e-05 | 31 | 50 | 3 | CID000038019 | |
| Drug | 4'-HPPH | 4.29e-05 | 31 | 50 | 3 | CID000017732 | |
| Drug | Tetrabenazine | 4.71e-05 | 5 | 50 | 2 | ctd:D013747 | |
| Drug | indole-2-carboxylic acid | 4.73e-05 | 32 | 50 | 3 | CID000072899 | |
| Drug | NNAL | 4.73e-05 | 32 | 50 | 3 | CID000104856 | |
| Drug | Muracein C | 4.73e-05 | 32 | 50 | 3 | CID003086323 | |
| Drug | trans-3,4,5-trihydroxystilbene | 4.93e-05 | 608 | 50 | 8 | CID000005056 | |
| Drug | AC1Q6OQG | 5.19e-05 | 33 | 50 | 3 | CID000009686 | |
| Disease | X-11793--oxidized bilirubin measurement | 2.40e-07 | 8 | 49 | 3 | EFO_0021260 | |
| Disease | Succinimide measurement | 2.40e-07 | 8 | 49 | 3 | EFO_0022118 | |
| Disease | X-11530 measurement | 2.40e-07 | 8 | 49 | 3 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 2.40e-07 | 8 | 49 | 3 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 2.40e-07 | 8 | 49 | 3 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 2.40e-07 | 8 | 49 | 3 | EFO_0800696 | |
| Disease | X-10458 measurement | 2.40e-07 | 8 | 49 | 3 | EFO_0800692 | |
| Disease | X-24849 measurement | 2.40e-07 | 8 | 49 | 3 | EFO_0800909 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 2.40e-07 | 8 | 49 | 3 | EFO_0802740 | |
| Disease | X-16946 measurement | 2.40e-07 | 8 | 49 | 3 | EFO_0800766 | |
| Disease | X-11442 measurement | 3.59e-07 | 9 | 49 | 3 | EFO_0021236 | |
| Disease | X-11441 measurement | 3.59e-07 | 9 | 49 | 3 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 3.59e-07 | 9 | 49 | 3 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 3.59e-07 | 9 | 49 | 3 | EFO_0801037 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 3.59e-07 | 9 | 49 | 3 | EFO_0802127 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 3.59e-07 | 9 | 49 | 3 | EFO_0801036 | |
| Disease | X-11880 measurement | 3.59e-07 | 9 | 49 | 3 | EFO_0800698 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 3.59e-07 | 9 | 49 | 3 | EFO_0004570, GO_0009410 | |
| Disease | protein-tyrosine kinase 6 measurement | 3.59e-07 | 9 | 49 | 3 | EFO_0020691 | |
| Disease | X-21448 measurement | 5.12e-07 | 10 | 49 | 3 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 5.12e-07 | 10 | 49 | 3 | EFO_0802185 | |
| Disease | X-23974 measurement | 5.12e-07 | 10 | 49 | 3 | EFO_0800867 | |
| Disease | bilirubin measurement, response to tenofovir | 5.12e-07 | 10 | 49 | 3 | EFO_0004570, EFO_0009279 | |
| Disease | X-21796 measurement | 7.03e-07 | 11 | 49 | 3 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 7.03e-07 | 11 | 49 | 3 | EFO_0004570, EFO_0004698 | |
| Disease | histidine betaine (hercynine) measurement | 7.03e-07 | 11 | 49 | 3 | EFO_0800972 | |
| Disease | aldosterone measurement | 7.03e-07 | 11 | 49 | 3 | EFO_0010219 | |
| Disease | biliverdin measurement | 9.37e-07 | 12 | 49 | 3 | EFO_0021033 | |
| Disease | p-cresol glucuronide measurement | 9.37e-07 | 12 | 49 | 3 | EFO_0800079 | |
| Disease | retinol dehydrogenase 16 measurement | 1.22e-06 | 13 | 49 | 3 | EFO_0802007 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 2.88e-06 | 17 | 49 | 3 | EFO_0004611, EFO_0007800 | |
| Disease | angiopoietin-related protein 1 measurement | 3.45e-06 | 18 | 49 | 3 | EFO_0801382 | |
| Disease | tissue factor measurement | 5.60e-06 | 21 | 49 | 3 | EFO_0010623 | |
| Disease | cocaine abuse (implicated_via_orthology) | 8.10e-06 | 3 | 49 | 2 | DOID:809 (implicated_via_orthology) | |
| Disease | xanthurenate measurement | 1.53e-05 | 29 | 49 | 3 | EFO_0010551 | |
| Disease | response to dolutegravir | 1.69e-05 | 30 | 49 | 3 | EFO_0600017 | |
| Disease | monocyte percentage of leukocytes | 2.51e-05 | 731 | 49 | 8 | EFO_0007989 | |
| Disease | amphetamine abuse (implicated_via_orthology) | 4.04e-05 | 6 | 49 | 2 | DOID:670 (implicated_via_orthology) | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 5.64e-05 | 7 | 49 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | urate measurement, spine bone mineral density | 1.25e-04 | 58 | 49 | 3 | EFO_0004531, EFO_0007701 | |
| Disease | age at menopause | 1.43e-04 | 302 | 49 | 5 | EFO_0004704 | |
| Disease | pregnenetriol sulfate measurement | 1.47e-04 | 11 | 49 | 2 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 1.47e-04 | 11 | 49 | 2 | EFO_0600039 | |
| Disease | pregnenetriol disulfate measurement | 2.08e-04 | 13 | 49 | 2 | EFO_0800587 | |
| Disease | chromosome 22q11.2 deletion syndrome, distal (implicated_via_orthology) | 2.43e-04 | 14 | 49 | 2 | DOID:0060413 (implicated_via_orthology) | |
| Disease | thyroxine measurement | 3.60e-04 | 83 | 49 | 3 | EFO_0005130 | |
| Disease | X-21441 measurement | 3.62e-04 | 17 | 49 | 2 | EFO_0800814 | |
| Disease | hormone measurement | 3.73e-04 | 84 | 49 | 3 | EFO_0004730 | |
| Disease | neutrophil count | 3.98e-04 | 1382 | 49 | 9 | EFO_0004833 | |
| Disease | cholelithiasis | 4.28e-04 | 88 | 49 | 3 | EFO_0004799 | |
| Disease | Ovarian Serous Adenocarcinoma | 6.68e-04 | 23 | 49 | 2 | C1335177 | |
| Disease | gallstones | 7.77e-04 | 108 | 49 | 3 | EFO_0004210 | |
| Disease | granulocyte percentage of myeloid white cells | 1.02e-03 | 268 | 49 | 4 | EFO_0007997 | |
| Disease | frontotemporal dementia | 1.30e-03 | 32 | 49 | 2 | MONDO_0017276 | |
| Disease | cervical cancer | 1.46e-03 | 34 | 49 | 2 | C4048328 | |
| Disease | non-alcoholic fatty liver disease (implicated_via_orthology) | 1.64e-03 | 36 | 49 | 2 | DOID:0080208 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GVPMVMMPLFGDQMD | 386 | P35503 | |
| LMTMAGMSGGPMGLA | 226 | Q13790 | |
| GDSMMDSPEMIAMQQ | 896 | Q9BXF3 | |
| MGMACLTMTEMEGTS | 1 | O60674 | |
| TVTALGMMESPMVSM | 891 | Q71F56 | |
| GMMESPMVSMVSTQL | 896 | Q71F56 | |
| NGVAMGMVAGTTMAM | 191 | Q92567 | |
| MSMPNVMTGTMGMAP | 551 | Q14677 | |
| GLTGTMGMGMPNIAM | 591 | Q14677 | |
| MGMGMPNIAMTSGTV | 596 | Q14677 | |
| EMPALIGMACVDTMM | 186 | Q8NHA6 | |
| GMGYMPSASMTRLMR | 311 | Q92597 | |
| LTDEMVMIMGGKMEA | 1996 | P42356 | |
| VHMLTGMESGVLMLM | 106 | Q8NGI0 | |
| VTMMPVTGGTINMME | 6 | Q9BUE0 | |
| AGGSVMGMMVTMMVF | 151 | O60404 | |
| PIIGTVSMDDMMLEM | 451 | P51843 | |
| MSVPTMAWMMLLLGL | 1 | A0A075B6I0 | |
| MGTHMPMAGDMNGLS | 506 | Q9H3D4 | |
| HGLLLFMMAGMTVSM | 301 | O43826 | |
| NMAAMFPMLLSGMAG | 2706 | Q3L8U1 | |
| MIMMEMTDFTRGKGP | 721 | P35221 | |
| VKSTLSMLPMMLPGM | 2511 | Q8TD26 | |
| MFLSPGMGMALPAMQ | 2626 | Q8TD26 | |
| ANMLGEMMFGSVAMS | 126 | Q8TF40 | |
| MDLSFMAAQLPMMGG | 1 | Q9NPU4 | |
| MAAQLPMMGGAFMDS | 6 | Q9NPU4 | |
| MTDPTMLTDMMKGNV | 101 | Q9P0I2 | |
| GNTISIFPTMMVCMM | 91 | Q5J8M3 | |
| GFMMSVAVGFPMMIL | 276 | Q9HBR0 | |
| SEAMSMPQMRTMASG | 546 | Q8NET4 | |
| QMKAMTSGAMSTPLM | 566 | Q8NET4 | |
| GMSMPLMRAQDPGVM | 691 | Q8NET4 | |
| QDPGGMSMSPMKSMT | 726 | Q8NET4 | |
| TMPMPLMSAMASGEM | 961 | Q8NET4 | |
| LMSAMASGEMSMPLM | 966 | Q8NET4 | |
| ASGEMSMPLMETMAS | 971 | Q8NET4 | |
| GCGMGMSMPQMTATD | 1051 | Q8NET4 | |
| MEFLPGGDMMTLLMK | 166 | Q15208 | |
| IMEFLPGGDMMTLLM | 166 | Q9Y2H1 | |
| RPMVISSGMQSMDTM | 151 | Q9NR45 | |
| MMKMLLDPMGGIVMT | 46 | P49368 | |
| GAMEIVAMDMKVSGM | 461 | Q9Y2G9 | |
| GRVPEMADLHRMMMG | 721 | Q15477 | |
| EMVMIMGGKMEATPF | 486 | A4QPH2 | |
| GMLPMGMYGAHIPTM | 291 | Q9UPG8 | |
| MMMVMQPEGLGAGEG | 1 | Q08043 | |
| TSSNPCGVMMQMMLG | 96 | Q8NBQ7 | |
| CGVMMQMMLGGMSPE | 101 | Q8NBQ7 | |
| FSMMLMTGMPQLTSK | 1031 | P48736 | |
| SAIEMMDPKMDAGMI | 61 | Q5VZE5 | |
| MALAMGFMPVDMGSL | 181 | Q658P3 | |
| KLTPMFLMVMPGMIS | 321 | P31639 | |
| GVPMVMMPLFGDQMD | 386 | P35504 | |
| IGNVMGQSPSMMVGM | 356 | Q8IYB5 | |
| MLPMKETGLMYSIMV | 3971 | P78527 | |
| MVMEYMPGGDLVNLM | 151 | Q13464 | |
| GVSMMDPNHFLMIML | 701 | Q8IWV8 | |
| MGIAMLEPALPIWMM | 306 | Q05940 | |
| GMVDSSMMPIMGYLV | 396 | Q05940 | |
| PMDPSNFVTMMGMGV | 606 | Q15637 | |
| TGQMDGIPMSMKNEM | 296 | Q96H15 | |
| AGPYVMMIGKMVANM | 986 | Q96QT4 | |
| LAIGMVDSSMMPIMG | 401 | P54219 | |
| GVPMVMMPLFGDQMD | 386 | P22310 | |
| MQMPAMMSLLLVSVG | 1 | P52961 |